Nova Leah Ltd., a Dundalk, Ireland-based provider of a cybersecurity compliance solution for medical device manufacturers and healthcare providers, raised €2.25M in funding.
The round was led by the Bank of Ireland Kernel Capital Growth Fund (RoI), with a €1.5M investment, with participation from Suir Valley Ventures.
The company intends to use the funds to continue to expand operations.
Led by Anita Finnegan, CEO, Nova Leah has developed a cybersecurity compliance solution for medical device manufacturers and healthcare providers to improve the security of connected medical devices, improve patient safety and reduce associated regulatory costs. SelectEvidence® provides a repeatable, traceable and auditable way to manage cybersecurity throughout the lifetime of a device. The system accurately tracks risks for each device, highlights known vulnerabilities, recommends solutions, provides a feedback mechanism between manufacturers and hospitals and does so within a fully traceable framework.
The platform has global deployments with a blue chip customer base.
The company is a spin out company from Dundalk Institute of Technology (DkIT).